Kellogg quarterly sales beat market expectations
Kellogg Co reported quarterly sales above market expectations on Tuesday, as the Corn Flakes cereal maker benefited from higher demand for its snacks such as...
Merck beats estimates as Keytruda sales top $3 billion for first time
Merck & Co Inc blew past Wall Street expectations for third-quarter profit on Tuesday, as sales of its blockbuster immunotherapy Keytruda crossed the $3-billion mark...
Oil slips to $61 on OPEC+ doubts, U.S. inventories in view
Oil slipped to around $61 a barrel on Tuesday, falling for a second day, pressured by expectations of a rise in U.S. crude inventories and...
GM quarterly profit falls but beats Wall St. estimates
General Motors Co on Tuesday posted a lower third-quarter profit but beat Wall Street estimates as strong U.S. sales of high-margin pickup trucks and SUVs...
Futures tick lower on mixed earnings reports
U.S. stock index futures edged lower on Tuesday as investors assessed a mixed batch of earnings reports, including from Google parent Alphabet and big drugmakers...
ConocoPhillips profit beats estimates on higher production
U.S. oil and gas company ConocoPhillips’ quarterly profit shot ahead of analysts’ estimates on Tuesday, as higher shale production offset the impact from lower crude...
Facebook, Google, Twitter urged to do more to combat fake news in EU
Facebook , Google and Twitter must do more to tackle fake news or face regulatory action, the European Commission said on Tuesday....
ConocoPhillips profit slumps 43% on lower oil prices, higher costs
ConocoPhillips reported a 43% drop in adjusted quarterly profit on Tuesday, dragged by lower crude prices and higher exploration expenses....
Pfizer beats profit estimates, raises 2019 earnings forecast
Pfizer Inc posted a third-quarter profit well ahead of analysts’ estimates on higher sales of breast cancer drug Ibrance and raised its earnings forecast for...
Merck profit beats estimates as Keytruda sales surge
Merck & Co Inc reported a better-than-expected quarterly profit on Tuesday and raised its full-year earnings forecast as sales of its blockbuster immunotherapy, Keytruda, crossed...